NEORAL

This brand name is authorized in United States. It is also authorized in Australia, Canada, France, Germany, Ireland, Japan, Netherlands, New Zealand, UK.

Active ingredients

The drug NEORAL contains one active pharmaceutical ingredient (API):

1	Ciclosporin UNII 83HN0GTJ6D - CYCLOSPORINE
	Ciclosporin (also known as ciclosporin A) is a cyclic polypeptide immunomodulator with immunosuppressant properties. It has been shown to prolong survival of allogeneic transplants in animals and significantly improved graft survival in all types of solid organ transplantation in man. Ciclosporin has also been shown to have an anti-inflammatory effect.
	Read more about Ciclosporin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NEORAL Oral solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AD01	Ciclosporin	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AD Calcineurin inhibitors
Discover more medicines within L04AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5632K, 5633L, 5634M, 5635N, 5636P, 6125J, 6232B, 6352H, 6353J, 6354K, 8657P, 8658Q, 8659R, 8660T, 8661W
CA	Health Products and Food Branch	02150662, 02150670, 02150689, 02150697, 02237671
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	12669984, 17175181
FR	Base de données publique des médicaments	61857901, 62758831, 63094408, 63107460, 64620722, 65272941, 65922428, 65981679, 67194943
GB	Medicines & Healthcare Products Regulatory Agency	143441, 143448, 143457, 143465, 23547, 23549, 23551, 34906, 373459, 373462, 373465, 53654
IE	Health Products Regulatory Authority	88100, 88101, 88102, 88103
JP	医薬品医療機器総合機構	3999004M3021, 3999004M4028, 3999004M5024, 3999004S2032
NL	Z-Index G-Standaard	14084457
NL	Z-Index G-Standaard, PRK	40827, 40835, 40843
NZ	Medicines and Medical Devices Safety Authority	3910, 3911, 3912, 3913, 3914
US	FDA, National Drug Code	0078-0246, 0078-0248, 0078-0274